Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Molecular and Cellular Biology

Abstract 3004: Functional analysis of ERG splice variants and their effect on c-myc expression in prostate cancer.

Anshu Rastogi, Shyh-Han Tan, Gyorgy Petrovics, Yongmei Chen, Taduru Sreenath, David G. McLeod, Shiv Srivastava and Albert Dobi
Anshu Rastogi
1Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shyh-Han Tan
1Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gyorgy Petrovics
1Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yongmei Chen
1Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Taduru Sreenath
1Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David G. McLeod
2Urology Service, Walter Reed National Military Medical Center, Bethesda, MD.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shiv Srivastava
1Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Albert Dobi
1Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.AM2013-3004 Published April 2013
  • Article
  • Info & Metrics
Loading
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC

Abstract

Introduction and Objectives: The oncogenic activation of ERG in prostate cancer has been well established in recent years. Towards understanding the functional role of ERG, our laboratory previously identified two major types of ERG splice variants in human prostate tumors: Type I, which encodes a full length prototypical ERG protein, and Type II, which encodes a truncated protein lacking the ETS DNA-binding domain. Analysis of clinico-pathologic data from patients and ratios of Type I/Type II ERG revealed that an increased ratio correlated with a higher Gleason sum and poorly differentiated phenotype. However, the functional significance of the ERG splice variants is not clearly understood. Studying the function and interaction of the individual splice variants can further enhance our understanding of ERG, and advance efforts towards its clinical utility in the treatment of prostate cancer.

Methods: Exogenous Type II ERG was expressed in TMPRSS2-ERG fusion harboring VCaP cells and endogenous levels of Type I ERG and C-MYC proteins were evaluated. Type I and Type II ERG were also co-transfected in various cell lines to examine interaction among splice variants and regulatory efficiency with luciferase reporter constructs. In addition, quantitative RNA expression data of C-MYC and Type I/Type II ERG ratio were assessed by correlation analysis in patient samples.

Results: Expression of exogenous Type II ERG resulted in a decrease in endogenous Type I ERG protein expression in VCaP cells in a dose dependent manner, with a concomitant decrease in C-MYC. This decrease was not observed in the other cell lines. Decreased regulatory efficiency of Type I ERG, by addition of Type II ERG, was also observed. Patient data analysis also revealed a positive correlation between C-MYC expression and increased Type I/Type II ratio.

Conclusions: Decreased Type I/Type II ratios in VCaP cells showed decreases in C-MYC, suggesting that modulation of Type II ERG alters Type I ERG and thus its regulation of C-MYC. This interference was not observed in other cell lines, indicating the interaction is context dependent. While Type I ERG positively regulated downstream targets, addition of Type II ERG decreased their expression, implying an interaction between splice variants. Analysis of patient data affirmed in vitro results, thus we propose that modulation of Type I/Type II ratio may regulate downstream targets including oncogenic C-MYC in prostate cancer, providing a strong rationale for the biomarker and therapeutic utility of ERG splice variants.

Funding source: DoD/CDMRP (PC073614) grant to S.S.

Citation Format: Anshu Rastogi, Shyh-Han Tan, Gyorgy Petrovics, Yongmei Chen, Taduru Sreenath, David G. McLeod, Shiv Srivastava, Albert Dobi. Functional analysis of ERG splice variants and their effect on c-myc expression in prostate cancer. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 3004. doi:10.1158/1538-7445.AM2013-3004

Note: This abstract was not presented at the AACR Annual Meeting 2013 because the presenter was unable to attend.

  • ©2013 American Association for Cancer Research
Back to top
Cancer Research: 73 (8 Supplement)
April 2013
Volume 73, Issue 8 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract 3004: Functional analysis of ERG splice variants and their effect on c-myc expression in prostate cancer.
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract 3004: Functional analysis of ERG splice variants and their effect on c-myc expression in prostate cancer.
Anshu Rastogi, Shyh-Han Tan, Gyorgy Petrovics, Yongmei Chen, Taduru Sreenath, David G. McLeod, Shiv Srivastava and Albert Dobi
Cancer Res April 15 2013 (73) (8 Supplement) 3004; DOI: 10.1158/1538-7445.AM2013-3004

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract 3004: Functional analysis of ERG splice variants and their effect on c-myc expression in prostate cancer.
Anshu Rastogi, Shyh-Han Tan, Gyorgy Petrovics, Yongmei Chen, Taduru Sreenath, David G. McLeod, Shiv Srivastava and Albert Dobi
Cancer Res April 15 2013 (73) (8 Supplement) 3004; DOI: 10.1158/1538-7445.AM2013-3004
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Molecular and Cellular Biology

  • Abstract DDT02-01: Inhibition of the AAA-ATPase p97 with the first in class inhibitor CB-5083 as a novel approach to treat cancer
  • Abstract RAOS15-03: Pancreatic tumor stroma as a therapeutic target
  • Abstract LB-307: Computational modeling of serous ovarian carcinoma dynamics: Implications for screening and therapy
Show more 3

Poster Presentations - Proffered Abstracts

  • Abstract DDT02-01: Inhibition of the AAA-ATPase p97 with the first in class inhibitor CB-5083 as a novel approach to treat cancer
  • Abstract RAOS15-03: Pancreatic tumor stroma as a therapeutic target
  • Abstract LB-307: Computational modeling of serous ovarian carcinoma dynamics: Implications for screening and therapy
Show more 3

Poster Presentations - Functional Identification of Cancer Genes

  • Abstract 3012: The CaSm oncogene promotes proliferation, invasion, and chemoresistance of pancreatic cancer cells.
  • Abstract 3008: IGF2 mRNA binding protein 1 drives growth, metastasis and chemoresistance in osteosarcoma.
  • Abstract 3014: Implication of ΔNp73 isoform in drug resistance.
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement